Skip to main content
Premium Trial:

Request an Annual Quote

Amit Kumar, Harald zur Hausen, Patrick Weiss, and Howard Sampson

Premium

Amit Kumar has joined the board of directors of Incara Pharmaceuticals, the Research Triangle Park, NC-based company said today. He is president and CEO as well as a director of CombiMatrix.

Kumar received a PhD from the California Institute of Technology and a bachelor's degree in chemistry from Occidental College in Los Angeles. He completed his postdoctoral studies at Harvard University in Cambridge, Mass.


Harald zur Hausen has joined the scientific advisory board of the German Resource Center for Genome Research, RZPD, in Berlin.


Patrick Weiss has become the CEO of Operon Biotechnologies following the synthetic DNA business’ sale by Qiagen. Weiss, who led the team of former Qiagen management members acquiring Operon, previously served as Qiagen’s vice president of gene silencing.


Vista Medical Technologies has appointed Howard Sampson as its new CFO.

Vista said that Sampson has been a consultant to the company since January. Previously, he served as CFO of Immune Response Corporation and Genta. Sampson, said Vista, is a CPA.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.